Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-25T08:20:12.809Z Has data issue: false hasContentIssue false

Explanatory and pragmatic trials

Published online by Cambridge University Press:  18 May 2011

Corrado Barbui*
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona
Antonio Veronese
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona
Andrea Cipriani
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona
*
Address for correspondence: Dr. C. Barbui, Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L.A. Scuro, 10 - 37134 Verona, Italy. Fax: +39-045-585.871 E-mail: [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
ABC of Methodology
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Geddes, J.R. (2005). Large simple trials in psychiatry: providing reliable answers to important clinical questions. Epidemiologia e Psichiatria Sociale 14, 122126.CrossRefGoogle ScholarPubMed
Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) (1986). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1, 397402.Google Scholar
Jones, P.B., Barnes, T.R., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K.P., Murray, R.M., Markwick, A. & Lewis, S.W. (2006). Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Archives of General Psychiatry 63, 10791087.CrossRefGoogle Scholar
Lieberman, J.A., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., Keefe, R.S., Davis, S.M., Davis, C.E., Lebowitz, B.D., Severe, J. & Hsiao, J.K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353, 12091223.CrossRefGoogle ScholarPubMed
March, J.S., Silva, S.G., Compton, S., Shapiro, M., Califf, R. & Krishnan, R. (2005). The case for practical clinical trials in psychiatry. American Journal of Psychiatry 162, 836846.CrossRefGoogle ScholarPubMed
Schwartz, D. & Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Diseases 20, 637648.CrossRefGoogle ScholarPubMed
Stroup, S. (2005). Practical clinical trials for schizophrenia. Epidemiologiae Psichiatria Sociale 14, 132136.CrossRefGoogle ScholarPubMed
Tognoni, G. & Franzosi, M.G. (2005). [Experimenting in Italy: from GISSI to the Ministerial Decree]. Recenti Progressi in Medicina 96, 9294.Google Scholar